Toll-like receptor 2 and renal allograft function

American Journal of Nephrology

Volumn 28, Issue 4, 2008, Pages 583-588

  De Groot, Kirsten ^a   Kuklik, Katharina ^a   Bröcker, Verena ^a   Schwarz, Anke ^a   Gwinner, Wilfried ^a   Kreipe, Hans ^a   Haller, Hermann ^a   Fliser, Danilo ^a   Mengel, Michael ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Kidney transplantation; Renal function; Toll like receptor 2

Indexed keywords

TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOMEGALOVIRUS INFECTION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY DISTAL TUBULE; KIDNEY PROXIMAL TUBULE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENAL GRAFT DYSFUNCTION; URINARY TRACT INFECTION;

BIOPSY; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; KIDNEY TUBULES, DISTAL; KIDNEY TUBULES, PROXIMAL; MALE; MIDDLE AGED; TIME FACTORS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TRANSPLANTATION, HOMOLOGOUS; URINARY TRACT INFECTIONS;

EID: 45149130326     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000115974     Document Type: Article

References (19)

1. Akira S, Takeda K, Kaisho T: Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001;2:675-680.
2. Janeway CA Jr, Medzhitov R: Innate immune recognition. Ann Rev Immunol 2002;20:197-216.
3. Anders HJ, Banas B, Schlondorff D: Signaling danger: Toll-like receptors and their potential roles in kidney disease. J Am Soc Nephrol 2004;15:854-867.
4. Anders HJ, Vielhauer V, Eis V, Linde Y, Kretzler M, Perez de Lema G, Strutz F, Bauer S, Rutz M, Wagner H, Grone HJ, Schlondorff D: Activation of toll-like receptor-9 induces progression of renal disease in mrl-fas(lpr) mice. FASEB J 2004;18:534-536.
5. El-Achkar TM, Dagher PC: Renal toll-like receptors: recent advances and implications for disease. Nat Clin Pract 2006;2:568-581.
6. Wolfs TG, Buurman WA, van Schadewijk A, de Vries B, Daemen MA, Hiemstra PS, van 't Veer C: In vivo expression of toll-like receptor 2 and 4 by renal epithelial cells: IFN-gamma and TNF-alpha mediated up-regulation during inflammation. J Immunol 2002;168:1286-1293.
7. Gill JS, Tonelli M, Mix CH, Pereira BJ: The change in allograft function among longterm kidney transplant recipients. J Am Soc Nephrol 2003;14:1636-1642.
8. Schwarz A, Mengel M, Gwinner W, Radermacher J, Hiss M, Kreipe H, Haller H: Risk factors for chronic allograft nephropathy after renal transplantation: a protocol biopsy study. Kidney international 2005;67:341-348.
9. Mengel M, Gwinner W, Schwarz A, Bajeski R, Franz I, Brocker V, Becker T, Neipp M, Klempnauer J, Haller H, Kreipe H: Infiltrates in protocol biopsies from renal allografts. Am J Transplant 2007;7:356-365.
10. Racusen LC, Colvin RB, Solez K, Mihatsch MJ, Halloran PF, Campbell PM, Cecka MJ, Cosyns JP, Demetris AJ, Fishbein MC, Fogo A, Furness P, Gibson IW, Glotz D, Hayry P, Hunsickern L, Kashgarian M, Kerman R, Magil AJ, Montgomery R, Morozumi K, Nickeleit V, Randhawa P, Regele H, Seron D, Seshan S, Sund S, Trpkov K: Antibody-mediated rejection criteria: an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003;3:708-714.
11. Mengel M, Werner M, von Wasielewski R: Concentration dependent and adverse effects in immunohistochemistry using the tyramine amplification technique. Histochem J 1999;31:195-200.
12. von Wasielewski R, Mengel M, Gignac S, Wilkens L, Werner M, Georgii A: Tyramine amplification technique in routine immunohistochemistry. J Histochem Cytochem 1997;45:1455-1459.
13. Leemans JC, Stokman G, Claessen N, Rouschop KM, Teske GJ, Kirschning CJ, Akira S, van der Poll T, Weening JJ, Florquin S: Renal-associated tlr2 mediates ischemia/reperfusion injury in the kidney. J Clin Invest 2005;115:2894-2903.
14. Chen L, Wang T, Zhou P, Ma L, Yin D, Shen J, Molinero L, Nozaki T, Phillips T, Uematsu S, Akira S, Wang CR, Fairchild RL, Alegre ML, Chong A: Tlr engagement prevents transplantation tolerance. Am J Transplant 2006;6:2282-2291.
15. Budde K, Liefeldt L, Slowinski T, Glander P: No evidence for a relationship between infiltrates in renal protocol biopsies and outcome. Am J Transplant 2007;7:2637-2638.
16. Mengel M, Brocker V, Schwarz A, Haller H, Gwinner W: Authors reply to Budde et al: 'No evidence for relationship between infiltrates in renal protocol biopsies and outcome'. Am J Transplant 2007;7:2639-2640.
17. Palmer SM, Burch LH, Mir S, Smith SR, Kuo PC, Herczyk WF, Reinsmoen NL, Schwartz DA: Donor polymorphisms in toll-like receptor-4 influence the development of rejection after renal transplantation. Clin Transplant 2006;20:30-36.
18. Ducloux D, Deschamps M, Yannaraki M, Ferrand C, Bamoulid J, Saas P, Kazory A, Chalopin JM, Tiberghien P: Relevance of toll-like receptor-4 polymorphisms in renal transplantation. Kidney Int 2005;67:2454-2461.
19. Methe H, Zimmer E, Grimm C, Nabauer M, Koglin J: Evidence for a role of toll-like receptor 4 in development of chronic allograft rejection after cardiac transplantation. Transplantation 2004;78:1324-1331.